Harm/ risk (analysis)

Latest Articles

Article
Risk of natalizumab-associated PML in patients with MS is reduced with extended interval dosing
Lana Zhovtis Ryerson, John Foley, Ih Chang, et al.

Neurology September 12, 2019
Editorial
Do good things come to those who wait?Dosing interval of natalizumab in MS
David B. Clifford, Kenneth L. Tyler

Neurology September 12, 2019
Article
Validation of a clinical-genetics score to predict hemorrhagic transformations after rtPA
Caty Carrera, Natalia Cullell, Nuria Torres-Águila, et al.

Neurology July 31, 2019
Article
High-dose methylprednisolone for acute traumatic spinal cord injuryA meta-analysis
Zhongyu Liu, Yang Yang, Lei He, et al.

Neurology July 29, 2019

Advertisement

Varied Phenotypes and Management of Immune Checkpoint Inhibitor Associated Neuropathies

Dr. Noah Kolb talks with Dr. Amanda Guidon about her paper on varied phenotypes and management of immune checkpoint inhibitor associated neuropathies

September 10, 2019 Issue

Neurology, Journal, podcast

Listen27:51

Disclosures

View Recent Podcasts